Abstract
The difference between chronological age and the apparent age of the brain estimated from brain imaging data — the brain age gap (BAG) — is widely considered a general indicator of brain health. Converging evidence supports that BAG is sensitive to an array of genetic and non-genetic traits and diseases, yet few studies have examined the genetic architecture and its corresponding causal relationships with common brain disorders. Here, we estimate BAG using state-of-the-art neural networks trained on brain scans from 53,542 individuals (age range 3-95 years). A genome-wide association analysis across 28,104 individuals (40-84 years) from the UK Biobank revealed eight independent genomic regions significantly associated with BAG (p<5×10−8) implicating neurological, metabolic, and immunological pathways – among which seven are novel. No significant genetic correlations or causal relationships with BAG were found for Parkinson’s disease, major depressive disorder, or schizophrenia, but two-sample Mendelian randomization indicated a causal influence of AD (p=7.9×10−4) and bipolar disorder (p=1.35×10−2) on BAG. These results emphasize the polygenic architecture of brain age and provide insights into the causal relationship between selected neurological and neuropsychiatric disorders and BAG.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is supported by Norwegian Research Council (No. 223273, 298646, 300767, 302854), the UiO:Life Science Convergence environment, University of Oslo, Norway, (4MENT), the South-Eastern Norway Regional Health Authority (2019101), KG Jebsen Stiftelsen, and the European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used to train the neural networks have previously been described here: https://www.sciencedirect.com/science/article/pii/S1053811922003342. Data used for genetic analyses comes from the UK Biobank: https://www.ukbiobank.ac.uk/ For other GWAS only summary stats were used
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated with acknowledgement to the UK Biobank
Data Availability
All data used in the study are from openly accessible datasets. Requests for the individual dataset have to be placed with the individual principal investigators
